| Can urinary biomarkers replace cystoscopy? M Maas, J Bedke, A Stenzl, T Todenhöfer World journal of urology 37, 1741-1749, 2019 | 48 | 2019 |
| Circulating tumor cells and their role in prostate cancer M Maas, M Hegemann, S Rausch, J Bedke, A Stenzl, T Todenhoefer Asian journal of andrology 21 (1), 24-31, 2019 | 28 | 2019 |
| Expression of tumour progression‐associated genes in circulating tumour cells of patients at different stages of prostate cancer GI Russo, S Bier, J Hennenlotter, G Beger, L Pavlenco, J van de Flierdt, ... BJU international 122 (1), 152-159, 2018 | 27 | 2018 |
| Molecular predictors of response to PD-1/PD-L1 inhibition in urothelial cancer V Stühler, JM Maas, J Bochem, IA da Costa, T Todenhöfer, A Stenzl, ... World Journal of Urology 37, 1773-1784, 2019 | 26 | 2019 |
| Enfortumab vedotin–next game-changer in urothelial cancer M Maas, V Stühler, S Walz, A Stenzl, J Bedke Expert Opinion on Biological Therapy 21 (7), 801-809, 2021 | 24 | 2021 |
| Performance of urinary markers for detection of upper tract urothelial carcinoma: is upper tract urine more accurate than urine from the bladder? S Bier, J Hennenlotter, M Esser, S Mohrhardt, S Rausch, C Schwentner, ... Disease Markers 2018 (1), 5823870, 2018 | 24 | 2018 |
| Immune checkpoint inhibition for the treatment of renal cell carcinoma V Stühler, JM Maas, S Rausch, A Stenzl, J Bedke Expert Opinion on Biological Therapy 20 (1), 83-94, 2020 | 20 | 2020 |
| Urine biomarkers in bladder cancer—Current status and future perspectives M Maas, T Todenhöfer, PC Black Nature Reviews Urology 20 (10), 597-614, 2023 | 19 | 2023 |
| Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer M Hegemann, M Maas, S Rausch, S Walz, J Bedke, A Stenzl, ... Asian Journal of Andrology 21 (1), 12-18, 2019 | 16 | 2019 |
| Bone health issues in patients with prostate cancer: an evidence-based review S Walz, M Maas, A Stenzl, T Todenhöfer The World Journal of Men's Health 38 (2), 151, 2020 | 13 | 2020 |
| Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma V Stühler, S Rausch, JM Maas, A Stenzl, J Bedke Expert Opinion on Biological Therapy 21 (9), 1215-1226, 2021 | 12 | 2021 |
| Molecular markers in disease detection and follow-up of patients with non-muscle invasive bladder cancer M Maas, S Walz, V Stühler, S Aufderklamm, S Rausch, J Bedke, A Stenzl, ... Expert Review of Molecular Diagnostics 18 (5), 443-455, 2018 | 12 | 2018 |
| Systemic alterations of Wnt inhibitors in patients with prostate cancer and bone metastases S Aufderklamm, J Hennenlotter, P Leidenberger, S Rausch, A Hohneder, ... Disease markers 2018 (1), 1874598, 2018 | 11 | 2018 |
| Prognostic impact of complete metastasectomy in metastatic renal cell carcinoma in the era of immuno-oncology-based combination therapies V Stühler, L Herrmann, M Maas, S Walz, S Rausch, A Stenzl, J Bedke World Journal of Urology 40 (5), 1175-1183, 2022 | 7 | 2022 |
| Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node‐positive bladder cancer M von Deimling, M Furrer, LS Mertens, A Mari, N van Ginkel, M Bacchiani, ... BJU international 133 (3), 341-350, 2024 | 6 | 2024 |
| Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard … T Todenhöfer, M Maas, M Ketz, N Kossack, C Colling, B Qvick, A Stenzl World Journal of Urology, 1-8, 2021 | 6 | 2021 |
| Prognostic impact of somatostatin receptor expression in advanced bladder cancer M Maas, L Mayer, J Hennenlotter, V Stuehler, S Walz, M Scharpf, U Kuehs, ... Urologic Oncology: Seminars and Original Investigations 38 (12), 935. e17 …, 2020 | 4 | 2020 |
| An evaluation of avelumab for the treatment of genitourinary tumors V Stuehler, JM Maas, S Walz, A Stenzl, J Bedke Expert Opinion on Biological Therapy 20 (9), 971-979, 2020 | 4 | 2020 |
| Flexible vesiculovasoscopy using a microoptical system in a human cadaver model: an experimental approach for atraumatic endoscopy of the seminal tract D Schlager, M Maas, S Hein, F Adams, M Schoenthaler, U Wetterauer, ... Journal of Endourology 30 (8), 934-938, 2016 | 4 | 2016 |
| A Protocol for Organoids from the Urine of Bladder Cancer Patients S Walz, P Pollehne, R Geng, J Schneider, M Maas, WK Aicher, A Stenzl, ... Cells 12 (17), 2188, 2023 | 3 | 2023 |
